The reports in this category analyze and forecast the revenues of the global genetic testing market and its various segments, such as predictive medicine and pharmacogenomic testing. These reports also cover the genomics technology markets for genoty ....see more
The global spatial genomics & transcriptomics market is projected to reach USD 404 million by 2025, at a CAGR of 17.8% during the forecast period. 10X Genomics (US), NanoString Technologies Inc. (US), Illumina Inc. (US), and Bio-Rad Laboratories (US) are the prominent players operating in the spatial genomics and transcriptomics market. Product launches, collaborations, agreements, expansions, and acquisitions are the key growth strategies adopted by a majority of the leading players in the spatial genomics and transcriptomics market to gain a competitive edge in the market.
The global medical device security market is projected to reach USD 6.59 Billion by 2023 from 4.36 Billion in 2018, at a CAGR of 8.6%. Factors such as increasing instances of healthcare cyberattacks and threats, growth in geriatric population and subsequent growth in chronic disease management, government regulations and need for compliance, growing demand for connected medical devices, and increasing adoption of cybersecurity solutions are driving the growth of the medical device security market. The prominent players in the global medical device security market include Cisco Systems (US), IBM Inc. (US), GE Healthcare (US), Symantec Inc.(US), CA Technologies (US), Philips (Netherlands), DXC Technology (US), CloudPassage (US), FireEye (US), Check Point Software Technologies (Israel), Sophos (UK), Imperva (US), Fortinet (US), Palo Alto Networks (US), ClearDATA (US), and Zscaler (US).
The global aptamers market is expected to reach $244.93 Million by 2020 from $107.56 Million in 2015, at a CAGR of 17.89%. Aptamers bind to target protein, lipid, or nucleic acid molecules with a high degree of specificity. Aptamers can be generated rapidly and applied in the specific detection, inhibition, and characterization of proteins. These can be used as pharmaceutical leads, detection reagents, and functional proteomic levels (with small molecules, antibodies, or other aptamers). The scope of this market report includes DNA-, RNA-, and XNA-based aptamers used for research applications.
The Global DNA & Gene Chip (microarray) market was valued at $760 million in 2010 and is expected to reach $1,425.2 million by 2015 growing at a CAGR of and 13.4%. The oDNA segment accounted for the largest share – 98% – of the global DNA & gene chip market in 2010.